New therapeutic avenues in lung cancer based on disturbances in PI3K and RAS pathways

被引：0
|
作者：
Rosell, R. [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Oncol, Badalona, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
G1
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [41] Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches
    Singh, Gursimran
    Rohit, Pankaj
    Kumar, Pankaj
    Aran, Khadga Raj
    MEDICAL ONCOLOGY, 2025, 42 (04)
  • [42] Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
    Barzegar Behrooz, Amir
    Talaie, Zahra
    Jusheghani, Fatemeh
    Los, Marek J.
    Klonisch, Thomas
    Ghavami, Saeid
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [43] Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond
    Chan, Jack J.
    Tan, Tira J. Y.
    Dent, Rebecca A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [44] The intersection of the PI3K/mTOR and HIPPO pathways: a potential therapeutic target for medulloblastoma
    Ronecker, Jennifer S.
    Lee, Paul
    Sridhara, Sudeepta
    LaBagnara, Michael
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2016, 76
  • [45] Biophysical and structural characterization of novel RAS-binding domains (RBDs) of PI3Kα and PI3Kγ
    Martinez, Nicholas G.
    Thieker, David F.
    Carey, Leiah M.
    Rasquinha, Juhi A.
    Kistler, Samantha K.
    Kuhlman, Brian A.
    Campbell, Sharon L.
    PROTEIN SCIENCE, 2021, 30 : 52 - 53
  • [46] Biophysical and Structural Characterization of Novel RAS-Binding Domains (RBDs) of PI3Kα and PI3Kγ
    Martinez, Nicholas G.
    Thieker, David F.
    Carey, Leiah M.
    Rasquinha, Juhi A.
    Kistler, Samantha K.
    Kuhlman, Brian A.
    Campbell, Sharon L.
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (08)
  • [47] Functional correlation between cancer stem cells and algorithmic effectiveness of targeted drugs of RAS and PI3K pathways in TNBC
    Aske, Jennifer C.
    De, Pradip K.
    Leyland-Jones, Brian
    Dey, Nandini
    CANCER RESEARCH, 2019, 79 (13)
  • [48] NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
    Rajendra Karki
    Si Ming Man
    R. K. Subbarao Malireddi
    Sannula Kesavardhana
    Qifan Zhu
    Amanda R. Burton
    Bhesh Raj Sharma
    Xiaopeng Qi
    Stephane Pelletier
    Peter Vogel
    Philip Rosenstiel
    Thirumala-Devi Kanneganti
    Nature, 2016, 540 : 583 - 587
  • [49] Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways
    Kiraly, Jozsef
    Szabo, Erzsebet
    Fodor, Petra
    Fejes, Zsolt
    Nagy Jr, Bela
    Juhasz, Eva
    Vass, Anna
    Choudhury, Mahua
    Konya, Gabor
    Halmos, Gabor
    Szabo, Zsuzsanna
    MOLECULES, 2023, 28 (18):
  • [50] Essential role of RAS and PI3K pathways in Flt3 dependent proliferation and survival.
    Mizuki, M
    Fenski, R
    Serve, S
    Matsumura, I
    Grüning, W
    Kratz-Albers, K
    Büchner, T
    Berdel, WE
    Kanakura, Y
    Serve, H
    BLOOD, 1999, 94 (10) : 262A - 263A
12345